17 alpha-hydroxylase deficiency risk factors: Difference between revisions
m (Mehrian.jafari moved page Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency risk factors to 17 alpha-hydroxylase deficiency risk factors) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{17 alpha-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Revision as of 17:30, 20 July 2017
|
17 alpha-hydroxylase deficiency Microchapters |
|
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency risk factors |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The most potent risk factor in the development of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency is the presence of family history of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency.[1]
Risk Factors
The most potent risk factor in the development of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency is presence of family history of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency.[1]
References
- ↑ 1.0 1.1 Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016